Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Jones

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2008
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serineSean M Smith, Jason M Uslaner, Lihang Yao, et al.
Molecular Cancer Therapeutics|February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug ConjugatesJoshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamstersSheo B Singh, John G Ondeyka, Weiguo Liu, et al.
Science Translational Medicine|March 25, 2026
Engineered zinc finger repressors induce a prolonged and selective repression of <i>SCN9A</i> in nociceptors of nonhuman primatesMohammad Samie, Toufan Parman, Mihika Jalan, et al.
Journal of Medicinal Chemistry|March 24, 2010
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonistsCharles A Blum, Timothy Caldwell, Xiaozhang Zheng, et al.
Journal of Medicinal Chemistry|May 28, 2004
(2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agentsHiroo Koyama, Daniel J Miller, Julia K Boueres, et al.
Nature|July 10, 2024
Interferon subverts an AHR-JUN axis to promote CXCL13<sup>+</sup> T cells in lupusCalvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Nature|April 9, 2025
Universal photonic artificial intelligence accelerationSufi R Ahmed, Reza Baghdadi, Mikhail Bernadskiy, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2008
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serineSean M Smith, Jason M Uslaner, Lihang Yao, et al.
Molecular Cancer Therapeutics|February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug ConjugatesJoshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamstersSheo B Singh, John G Ondeyka, Weiguo Liu, et al.
Science Translational Medicine|March 25, 2026
Engineered zinc finger repressors induce a prolonged and selective repression of <i>SCN9A</i> in nociceptors of nonhuman primatesMohammad Samie, Toufan Parman, Mihika Jalan, et al.
Journal of Medicinal Chemistry|March 24, 2010
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonistsCharles A Blum, Timothy Caldwell, Xiaozhang Zheng, et al.
Journal of Medicinal Chemistry|May 28, 2004
(2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agentsHiroo Koyama, Daniel J Miller, Julia K Boueres, et al.
Nature|July 10, 2024
Interferon subverts an AHR-JUN axis to promote CXCL13<sup>+</sup> T cells in lupusCalvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Nature|April 9, 2025
Universal photonic artificial intelligence accelerationSufi R Ahmed, Reza Baghdadi, Mikhail Bernadskiy, et al.
Pageof 18